TNF and psoriasis: Humanized anti-TNF-α monoclonal antibodies (anti-TNF-α mAB) such as infliximab are used in the treatment of rheumatic and autoimmune diseases, including rheumatoid arthritis or psoriasis as well as GI diseases such as CD and UC.